The head of New Zealand's biggest pharmaceutical company says changes to Pharmac are a big concern, but the real issue of the Trans Pacific Partnership is agriculture.
The latest round of negotiations starts in Auckland this week and agriculture and the pharmaceutical industry are likely to
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Caleb Allison
Mon, 03 Dec 2012
Mon, 03 Dec 2012
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
NZ's drug kingpin on TPP deal
25966